In a fiery debate revelation, Donald Trump accuses pharmaceutical giants of a COVID-19 cover-up, vowing to force transparency on the pandemic's origins if re-elected. RFK Jr. backs the claim, igniting a new political firestorm.
A groundbreaking new hypertension drug, Baxdrostat, developed by AstraZeneca, has demonstrated remarkable success in clinical trials, potentially offering new hope for millions with treatment-resistant high blood pressure in the UK.
Former President Trump's proposed tariffs could severely restrict UK supplies and drastically increase prices for diabetes and weight-management medications like Ozempic, Wegovy, and Mounjaro, creating a new healthcare crisis.
Eli Lilly suspends shipments of obesity drug Mounjaro to the UK, triggering a major price surge and leaving thousands of patients in limbo amid supply chain restructuring.
Health Secretary Wes Streeting takes hardline stance in crucial NHS drug pricing negotiations with pharmaceutical giants, demanding better value for taxpayers while facing industry resistance.
A potential second Trump presidency could trigger massive price hikes for life-changing diabetes and obesity medications due to proposed import tariffs, putting essential treatments at risk for millions of Britons.
Health Secretary Wes Streeting confronts major pharmaceutical firms, demanding transparency and fair pricing in the NHS's voluntary rebate scheme, which recouped £1.4bn last year.
An explosive investigation reveals how pharmaceutical giant Novartis leveraged a WHO-led initiative to push its expensive cancer drug in Nigeria and Kenya, raising serious ethical concerns about Big Pharma's role in public health.
The cost of diabetes and weight-loss drugs Mounjaro and Ozempic has surged, sparking concerns over affordability and market competition. Experts weigh in on the implications.
Popular diabetes and weight-loss drugs Ozempic and Mounjaro face price hikes as Trump-era tariffs on Chinese imports take effect. Experts warn of potential shortages and financial strain on patients.
Pharmaceutical giant Eli Lilly announces a significant price increase for its diabetes and weight-loss drug Mounjaro in the UK, sparking concerns over affordability and access.
Former Florida Attorney General Pam Bondi faces ethics complaints for allegedly lobbying the Justice Department on behalf of a pharmaceutical company while serving on a federal drug enforcement board.
A pharmaceutical executive faces charges after a horrific wrong-way collision claimed the life of a former Olympic swimmer. The shocking incident has sent shockwaves through the community.
The pharmaceutical giant behind Mounjaro unveils an ambitious initiative to combat obesity in the UK, offering hope for millions struggling with weight-related health issues.
Pharmaceutical giant Eli Lilly is developing an oral weight loss drug that may compete with injectable treatments like Wegovy. Early trials show promising results, potentially offering a more convenient alternative for patients.
Delhi authorities have busted a massive counterfeit drug operation, with fake versions of Johnson & Johnson and GSK products seized. The racket poses serious health risks to consumers.
The US Food and Drug Administration (FDA) has approved a new Alzheimer's treatment, sparking debate over its efficacy and high cost while offering hope to millions.
Shares in major European pharmaceutical firms plummet as investors react to potential US tariffs, sparking market volatility and sector-wide uncertainty.
Sales of Novo Nordisk's blockbuster diabetes medications, including Ozempic, have dropped unexpectedly. Experts weigh in on the causes and future implications.
Former US President Donald Trump has floated the idea of imposing tariffs on imported pharmaceuticals, a move that could significantly impact the UK's healthcare sector and drug prices.
Former President Donald Trump’s controversial proposal to slash drug prices has reignited tensions with pharmaceutical giants. Critics warn of risks to innovation, while advocates hail it as a win for patients.
Labour leader Keir Starmer vows to confront pharmaceutical giants over soaring drug prices, promising relief for the NHS and patients. Will his strategy work?
Former US President Donald Trump calls on British pharmaceutical companies to reduce drug prices for the NHS, sparking debate on healthcare affordability.
New US tariffs could drastically increase the cost of essential medicines in Australia, putting the Pharmaceutical Benefits Scheme at risk. Experts warn of dire consequences for patients.
Biotech leader Moderna announces major layoffs, axing 150 jobs as part of a strategic cost-reduction plan. What does this mean for the future of mRNA vaccines?
AstraZeneca's CEO highlights the critical role of the US market amid looming Trump tariffs, emphasising the need for stable trade policies to sustain pharmaceutical innovation.
Novo Nordisk's blockbuster weight-loss drug Wegovy drives record sales, boosting shares and intensifying competition with Eli Lilly.
Pharmaceutical giant AstraZeneca faces a sharp decline in share prices following an unfavourable US court ruling, sparking investor concerns.
A US couple has been sentenced after authorities discovered their home packed with illegal erectile dysfunction drugs worth thousands.
Pharmaceutical giant AstraZeneca announces a bold $1.5bn US expansion despite looming tariff threats from the Trump administration, signalling confidence in transatlantic trade resilience.